Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1996 2
1997 1
1998 1
1999 1
2000 4
2001 3
2003 1
2006 1
2009 1
2012 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
IIb's are not IIb's.
Kereiakes DJ, Runyon JP, Broderick TM, Shimshak TM. Kereiakes DJ, et al. Among authors: runyon jp. Am J Cardiol. 2000 Apr 27;85(8A):23C-31C. doi: 10.1016/s0002-9149(00)00876-6. Am J Cardiol. 2000. PMID: 10793177
A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia.
Losordo DW, Kibbe MR, Mendelsohn F, Marston W, Driver VR, Sharafuddin M, Teodorescu V, Wiechmann BN, Thompson C, Kraiss L, Carman T, Dohad S, Huang P, Junge CE, Story K, Weistroffer T, Thorne TM, Millay M, Runyon JP, Schainfeld R; Autologous CD34+ Cell Therapy for Critical Limb Ischemia Investigators. Losordo DW, et al. Among authors: runyon jp. Circ Cardiovasc Interv. 2012 Dec;5(6):821-30. doi: 10.1161/CIRCINTERVENTIONS.112.968321. Epub 2012 Nov 27. Circ Cardiovasc Interv. 2012. PMID: 23192920 Free PMC article. Clinical Trial.
Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management.
Dippel EJ, Kereiakes DJ, Tramuta DA, Broderick TM, Shimshak TM, Roth EM, Hattemer CR, Runyon JP, Whang DD, Schneider JF, Abbottsmith CW. Dippel EJ, et al. Among authors: runyon jp. Catheter Cardiovasc Interv. 2001 Mar;52(3):279-86. doi: 10.1002/ccd.1065. Catheter Cardiovasc Interv. 2001. PMID: 11246236
Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
Kereiakes DJ, Broderick TM, Roth EM, Whang D, Shimshak T, Runyon JP, Hattemer C, Schneider J, Lacock P, Mueller M, Abbottsmith CW. Kereiakes DJ, et al. Among authors: runyon jp. Am J Cardiol. 1999 Aug 15;84(4):391-5. doi: 10.1016/s0002-9149(99)00321-5. Am J Cardiol. 1999. PMID: 10468074 Clinical Trial.
18 results